Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US1638511089
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG005H82GB2
CC
Chemours Co
GICS: Materials · SECTOR: EQTY · SUB-SECTOR: Chemicals - Specialty
NAME
Chemours Co
ISIN
US1638511089
TICKER
CC
MIC
XNYS
REUTERS
CC.N
BLOOMBERG
CC US
Mon, 19.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 19, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE: CC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of th...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.10.2026       Chemours
US1638511089

Action reflects Chemours' commitment to innovation, intellectual property protection, our customers, and fair competition in the refrigerants industryWILMINGTON, Del., Oct. 19, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company, today announces that it has taken action to protect its intellectual property...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 17.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 17.10.2026       Chemours
US1638511089

NEW ORLEANS, Oct. 16, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company ("Chemours" or the "Company") (NYSE: CC), if they purchased or otherwise acquired The Chemours...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 16.10.2026       Chemours
US1638511089

Did you buy CC securities between February 20, 2026 and August 4, 2026?Affected CC Investor SummaryWho: The Chemours Company (NYSE: CC)What: Securities fraud class action lawsuit filedClass Period: February 20, 2026 through August 4, 2026Deadline to Seek Lead Plaintiff Status: December 7, 2026Key Lawsuit Allegations: Material misstatements and/or...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 16.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 16, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 15.10.2026       Chemours
US1638511089

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 7, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the “...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 15.10.2026       Chemours
US1638511089

Notice to Pension Funds, Asset Managers, and Fiduciaries: The lawsuit alleges Chemours overstated aftermarket demand for its Opteon refrigerants and reaffirmed 2026 guidance that did not account for sales pulled forward by 2025 distributor stocking.NEW YORK, Oct. 15, 2026 /PRNewswire/ -- SueWallSt notifies pension funds, asset managers, and other i...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 15.10.2026       Chemours
US1638511089

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours " or the "Company") (NYSE: CC) and certain officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 26-cv-01299, is on behalf of a class cons...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Thu, 15.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 14.10.2026       Chemours
US1638511089

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against The Chemours Company (“Chemours”) (NYSE: CC) on behalf of those who purchased or acquired Chemours securities between February 20, 2026 and August 4, 20...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 14.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 14, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE: CC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of th...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 14.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 14.10.2026       Chemours
US1638511089

Wall Street Reassessment: Analyst Opinion Evolution on CC. UBS, Morgan Stanley, and J.P. Morgan cut Chemours price targets by as much as 37.9% after a 2026 guidance cut that the lawsuit alleges followed months of overstated Opteon aftermarket demand.NEW YORK, Oct. 14, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP tracks the Chemours analyst downgr...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 13.10.2026       Chemours
US1638511089

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and certain of the company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws.If you invested in Chemours, you...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 13.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 13.10.2026       Chemours
US1638511089

NEW YORK, Oct. 13, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE: CC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securiti...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 13.10.2026       Chemours
US1638511089

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (“Chemours” or the “Company”) (NYSE: CC), if they purcha...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 12.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company (“The Chemours” or the “Company”) (NASDAQ: CC) and reminds investors of the December 7, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. This...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 12.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 12, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 12.10.2026       Chemours
US1638511089

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 12.10.2026       Chemours
US1638511089

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) common stock between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours investors have until December 7, 2026 to file a lead plaintiff moti...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sun, 11.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 11, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE: CC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of th...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sun, 11.10.2026       Chemours
US1638511089

The DJS Law Group reminds investors of a class action lawsuit against The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CC during the cla...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 10.10.2026       Chemours
US1638511089

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchang...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 09.10.2026       Chemours
US1638511089

Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired The Chemours Company (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours offers a range of industrial and specialty chemical products fo...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 09.10.2026       Chemours
US1638511089

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) common stock between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours investors have until December 7, 2026 to...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 28.09.2026       Chemours
US1638511089

Industry underscores the need for science-based transition timelines that protect climate, vehicle safety, and consumer mobilityWILMINGTON, Del., Sept. 28, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company, today announces its strong support for the automotive industry's ask for an extended transition ti...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 28.09.2026       Chemours
US1638511089

Die Branche betont die Notwendigkeit wissenschaftlich fundierter Übergangsfristen, die den Klimaschutz, die Fahrzeugsicherheit und die Mobilität der Verbraucher gewährleisten WILMINGTON, Delaware, 28. September 2026 /PRNewswire/ -- The Chemours Company („Chemours") (NYSE: CC), ein weltweit tätiges Chemieunternehmen, gibt heute bekannt, dass es die...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 10.09.2026       Chemours
US1638511089

Resolves litigations brought by the State of North Carolina and 11 local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contamination unrelated to that site, including from the use of aqueous film forming foam ("AFFF").Overall settlement payments total $455 million over 15 y...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Chemours
US1638511089

NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The invest...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 27.08.2026       Chemours
US1638511089

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 25.08.2026       Chemours
US1638511089

WILMINGTON, Del., Aug. 25, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the release of its 2025 Sustainability Report."Our sustainability st...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 13.08.2026       Chemours
US1638511089

Das Instrument 2CU US1638511089 CHEMOURS CO. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 14.08.2026 The instrument 2CU US1638511089 CHEMOURS CO. DL-,01 EQUITY has its ex-dividend/interest day on 14.08.2026...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 13.08.2026       Chemours
US1638511089

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CH...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 13.08.2026       Chemours
US1638511089

Law Offices of Howard G. Smith announces an investigation on behalf of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN THE CHEMOURS COMPANY (CC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIAL...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 10.08.2026       Chemours
US1638511089

New additions to the Opteon™ portfolio support high-performance, sustainable cooling solutions in stationary chillers for AI-driven data centers, and commercial HVAC applicationsWILMINGTON, Del., Aug. 10, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced the launch of Opteon™ ZE (R-1234ze(...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       Chemours
US1638511089

WILMINGTON, Del., Aug. 4, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the third quarter of 2026. The dividend will be paid on September 15, 2026, to stockholders of record as of the...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       Chemours
US1638511089

WILMINGTON, Del., Aug. 4, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced its financial results for the second quarter...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 23.07.2026       Chemours
US1638511089

WILMINGTON, Del., July 23, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its second quarter 2026 financial results after market on Tuesday, August 4, 2026.The Company expects to hold its conference call to discuss its second quarter 2026 financial results at 8:0...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 24.06.2026       Chemours
US1638511089

The settlement resolves the federal government's claims relating to discharge of PFAS compounds across three current operating sites, as well as certain environmental claims by the State of West Virginia.  Chemours is expected to pay EPA and WVDEP a $22.5 million civil penalty over a three-year period, and fund $90 million in additional mitigation...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 14.05.2026       Chemours
US1638511089

Das Instrument 2CU US1638511089 CHEMOURS CO. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 15.05.2026 The instrument 2CU US1638511089 CHEMOURS CO. DL-,01 EQUITY has its ex-dividend/interest day on 15.05.2026...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 13.05.2026       Chemours
US1638511089

Eine neue, wertschöpfungskettenübergreifende Studie zeigt praktische Wege zu einer schnelleren Emissionsminderung auf und senkt das Risiko kostspieliger Klimaanlagenreparaturen bei geringen Kosten für die VerbraucherWILMINGTON, Delaware, 13. Mai 2026 /PRNewswire/ -- Eine heute veröffentlichte neue Branchenstudie, die von einer technischen Arbeitsg...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 13.05.2026       Chemours
US1638511089

New cross-value-chain research outlines practical pathways to faster emissions reductions, lowering the risk of expensive AC repairs at low cost to consumersWILMINGTON, Del., May 13, 2026 /PRNewswire/ -- A new industry study released today and developed by a technical working group co-led by The Chemours Company (Chemours) (NYSE: CC) and Solstice...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 06.05.2026       Chemours
US1638511089

WILMINGTON, Del., May 5, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the second quarter of 2026. The dividend will be paid on June 16, 2026, to stockholders of record as of the clos...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 05.05.2026       Chemours
US1638511089

WILMINGTON, Del., May 5, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced its financial results for the first quarter 2...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.04.2026       Chemours
US1638511089

WILMINGTON, Del., April 21, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its first quarter 2026 financial results after market on Tuesday, May 5, 2026.The Company expects to hold its conference call to discuss its first quarter 2026 financial results at 8:00 a....
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 12.03.2026       Chemours
US1638511089

WILMINGTON, Del., March 12, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced it completed its previously announced private offering of $700,000,000 in aggregate principal amount of 7.875% senior unsecured notes due 2034 (the "Notes") that was exempt from the registration requirements of the Securities Act of 1933, as...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 12.03.2026       Chemours
US1638511089

NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink